Wang Chao, Chen Zhen, Nie Litong, Tang Mengfan, Feng Xu, Su Dan, Zhang Huimin, Xiong Yun, Park Jeong-Min, Chen Junjie
Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Oncogenesis. 2020 Sep 28;9(9):85. doi: 10.1038/s41389-020-00271-1.
The ERK1/2 pathway is one of the most commonly dysregulated pathways in human cancers and controls many vital cellular processes. Although many ERK1/2 kinase substrates have been identified, the diversity of ERK1/2 mediated processes suggests the existence of additional targets. Here, we identified Deoxyhypusine synthase (DHPS), an essential hypusination enzyme regulating protein translation, as a major and direct-binding protein of ERK1/2. Further experiments showed that ERK1/2 phosphorylate DHPS at Ser-233 site. The Ser-233 phosphorylation of DHPS by ERK1/2 is important for its function in cell proliferation. Moreover, we found that higher DHPS expression correlated with poor prognosis in lung adenocarcinoma and increased resistance to inhibitors of the ERK1/2 pathway. In summary, our results suggest that ERK1/2-mediated DHPS phosphorylation is an important mechanism that underlies protein translation and that DHPS expression is a potent biomarker of response to therapies targeting ERK1/2-pathway.
ERK1/2信号通路是人类癌症中最常失调的信号通路之一,它控制着许多重要的细胞过程。尽管已经鉴定出许多ERK1/2激酶底物,但ERK1/2介导的过程的多样性表明还存在其他靶点。在这里,我们鉴定出脱氧hypusine合酶(DHPS),一种调节蛋白质翻译的必需hypusination酶,是ERK1/2的主要直接结合蛋白。进一步的实验表明,ERK1/2在Ser-233位点磷酸化DHPS。ERK1/2对DHPS的Ser-233磷酸化对其在细胞增殖中的功能很重要。此外,我们发现较高的DHPS表达与肺腺癌的不良预后相关,并增加了对ERK1/2通路抑制剂的抗性。总之,我们的结果表明,ERK1/2介导的DHPS磷酸化是蛋白质翻译的重要机制,并且DHPS表达是针对ERK1/2通路的治疗反应的有效生物标志物。